Tag: OTC:IGXT

October 9, 2019

IntelGenx Receives DSMB Recommendation for Phase 2a Trial

The Data Safety Monitoring Board completed its analysis of the company's Montelukast VersaFilm Phase 2a clinical trial of Alzheimer's Disease.
September 4, 2019

IntelGenx Partners with Tilray to Create Cannabis-infused Oral Strips

One pharmaceutical company is giving consumers the chance to experience the effects of cannabis in a new form: oral strips.